Philip He
1 appearance in the program
Sessions & presentations
PS38: Integrating Biomarker Discovery and Dose-optimization to Drive Drug Development Success
CoAuthor
Presentation: Bayesian Dynamic Borrowing for Dose-Specific Biomarker Cutoff Selection in Randomized Phase II Oncology Trials
Parallel · Fri, Sep 18 , 10:45 AM